ArticleBMC surgery2025
Impact of sarcopenia on short- and long-term outcomes following major hepatectomy for malignancy.
Article in BMC surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSarcopenia is increasingly recognized as a major prognostic factor in liver surgery. The present study aimed to investigate the impact of preoperative sarcopenia on postoperative morbidity and mortality following major hepatectomy for malignant liver tumours.
methodsThe present retrospective cohort study included 104 patients who underwent major hepatectomy between 2019 and 2024. Sarcopenia was assessed using preoperative computed tomography scans to calculate the L3 skeletal muscle index (L3-SMI), with established sex-specific cut-offs. Postoperative outcomes were compared between sarcopenic and nonsarcopenic patients.
resultsOf the 104 patients, 56 (53.8%) were classified as having sarcopenia. Sarcopenic patients had a significantly lower Body mass ındex (26.4 ± 3.7 vs. 28.4 ± 4.0 kg/m²; p = 0.011) and a greater proportion of males (71.4% vs. 41.7%; p = 0.002). Although there was a higher rate of postoperative morbidity in sarcopenic patients (55.3% vs. 39.6%), the difference did not reach statistical significance (p = 0.108). No significant differences were found in 90-day mortality (10.7% vs. 12.5%, p = 0.776) or long-term mortality (66.1% vs. 58.3%, p = 0.416) between the groups.
conclusionPreoperative sarcopenia is associated with a higher risk of postoperative morbidity following major hepatectomy. However, preoperative sarcopenia does not significantly affect short-term or long-term mortality. Routine assessment of muscle mass should be considered in preoperative evaluations to identify vulnerable patients and tailor perioperative management strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.